Aaron S. Coyner

Aaron S. Coyner

Auto-generated profile, based on publicly available information

Aaron S. Coyner

Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Ophthalmology Retina
Verified
Journal Article
Closed access
ACAaron S. Coyner
Aaron S. Coyner
RSRyan Swan
Ryan Swan
JCJ. Peter Campbell
J. Peter Campbell
SOSusan Ostmo
Susan Ostmo
JBJames Brown
James Brown
CMCristina Montero-Mendoza
Cristina Montero-Mendoza

1 March 2017 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
RRRenee Ryals
Renee Ryals
MAMichael D. Andrews
Michael D. Andrews
SDShreya Datta
Shreya Datta
ACAaron S. Coyner
Aaron S. Coyner
CFCody M. Fischer
Cody M. Fischer
TMTrevor J. McGill
Trevor J. McGill
Purpose: Prospective treatments for age-related macular degeneration and inherited retinal degenerations are commonly evaluated in the Royal College of Surgeons (RCS) rat before translation into clinical application. Historically, retinal thickness obtained through postmortem anatomic assessments has been a key outcome measure; however, utility of this measurement is limited because it precludes the ability to perform longitudinal studies. To overcome this limitation, the present study was designed to provide a baseline longitudinal quantification of retinal thickness in the RCS rat by using spectral-domain optical coherence tomography (SD-OCT). Methods: Horizontal and vertical linear SD-OCT scans centered on the optic nerve were captured from Long-Evans control rats at P30, P60, P90 and from RCS rats between P17 and P90. Total retina (TR), outer nuclear layer+ (ONL+), inner nuclear layer (INL), and retinal pigment epithelium (RPE) thicknesses were quantified. Histologic sections of RCS retina obtained from P21 to P60 were compared to SD-OCT images. Results: In RCS rats, TR and ONL+ thickness decreased significantly as compared to Long-Evans controls. Changes in INL and RPE thickness were not significantly different between control and RCS retinas. From P30 to P90 a subretinal hyperreflective layer (HRL) was observed and quantified in RCS rats. After correlation with histology, the HRL was identified as disorganized outer segments and the location of accumulated debris. Conclusions: Retinal layer thickness can be quantified longitudinally throughout the course of retinal degeneration in the RCS rat by using SD-OCT. Thickness measurements obtained with SD-OCT were consistent with previous anatomic thickness assessments. This study provides baseline data for future longitudinal assessment of therapeutic agents in the RCS rat.

11 February 2022 in Ophthalmology Science
Verified
Journal Article
Open access
ACAaron S. Coyner
Aaron S. Coyner
JCJimmy S. Chen
Jimmy S. Chen
KCKen Chang
Ken Chang
PSPraveer Singh
Praveer Singh
SOSusan Ostmo
Susan Ostmo
JCJ. Peter Campbell
J. Peter Campbell
Developing robust artificial intelligence (AI) models for medical image analysis requires large quantities of diverse, well-chosen data that can prove challenging to collect because of privacy concerns, disease rarity, or diagnostic label quality. Collecting image-based datasets for retinopathy of prematurity (ROP), a potentially blinding disease, suffers from these challenges. Progressively growing generative adversarial networks (PGANs) may help, because they can synthesize highly realistic images that may increase both the size and diversity of medical datasets. Diagnostic validation study of convolutional neural networks (CNNs) for plus disease detection, a component of severe ROP, using synthetic data. Five thousand eight hundred forty-two retinal fundus images (RFIs) collected from 963 preterm infants. Retinal vessel maps (RVMs) were segmented from RFIs. PGANs were trained to synthesize RVMs with normal, pre-plus, or plus disease vasculature. Convolutional neural networks were trained, using real or synthetic RVMs, to detect plus disease from 2 real RVM test datasets. Features of real and synthetic RVMs were evaluated using uniform manifold approximation and projection (UMAP). Similarities were evaluated at the dataset and feature level using Fréchet inception distance and Euclidean distance, respectively. CNN performance was assessed via area under the receiver operating characteristic curve (AUC); AUCs were compared via bootstrapping and Delong’s test for correlated receiver operating characteristic curves. Confusion matrices were compared using McNemar’s chi-square test and Cohen’s κ value. The CNN trained on synthetic RVMs showed a significantly higher AUC (0.971; P = 0.006 and P = 0.004) and classified plus disease more similarly to a set of 8 international experts (κ = 0.922) than the CNN trained on real RVMs (AUC = 0.934; κ = 0.701). Real and synthetic RVMs overlapped, by plus disease diagnosis, on the UMAP manifold, showing that synthetic images spanned the disease severity spectrum. Fréchet inception distance and Euclidean distances suggested that real and synthetic RVMs were more dissimilar to one another than real RVMs were to one another, further suggesting that synthetic RVMs were distinct from the training data with respect to privacy considerations. Synthetic datasets may be useful for training robust medical AI models. Furthermore, PGANs may be able to synthesize realistic data for use without protected health information concerns.

1 July 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
BTBrandon E. Tullis
Brandon E. Tullis
RRRenee C. Ryals
Renee C. Ryals
ACAaron S. Coyner
Aaron S. Coyner
MGMichael J. Gale
Michael J. Gale
NANicholson Alex
Nicholson Alex
MPMark E. Pennesi
Mark E. Pennesi
Purpose: To determine if sarpogrelate, a selective 5-HT2A receptor antagonist, is protective against light-induced retinopathy in BALB/c mice. Methods: BALB/c mice were dosed intraperitoneally with 5, 15, 30, 40, or 50 mg/kg sarpogrelate 48, 24, and 0 hours prior to bright light exposure (10,000 lux) as well as 24 and 48 hours after exposure. Additionally, a single injection regimen was evaluated by injecting mice with 50 mg/kg sarpogrelate once immediately prior to light exposure. To investigate the potential for additive effects of serotonin receptor agents, a combination therapy consisting of sarpogrelate (15 mg/kg) and 8-OH-DPAT (1 mg/kg) was evaluated with the 5-day treatment regimen. Neuroprotection was characterized by the preservation of retinal thickness and function, measured by spectral-domain optical coherence tomography (SD-OCT) and electroretinography (ERG), respectively. Results: Mice that were light damaged and injected with saline had significantly reduced outer retinal thickness, total retinal thickness, and ERG amplitudes compared with naïve mice. A 5-day administration of 15, 30, or 40 mg/kg of sarpogrelate was able to partially protect retinal morphology and full protection of retinal morphology was achieved with a 50 mg/kg dose. Both 15 and 30 mg/kg doses of sarpogrelate partially preserved retinal function measured by ERG, whereas 40 and 50 mg/kg doses fully preserved retinal function. Additionally, a single administration of 50 mg/kg sarpogrelate was able to fully preserve both retinal morphology and function. Administration of 15 mg/kg of sarpogrelate and 1 mg/kg of 8-OH-DPAT together demonstrated an additive effect and fully preserved retinal morphology. Conclusions: A 5- or 1-day treatment with 50 mg/kg sarpogrelate can completely protect the retina of BALB/c mice from light-induced retinopathy. Partial protection can be achieved with lower doses starting at 15 mg/kg and protection increases in a dose-dependent manner. Treatment with low doses of sarpogrelate and 8-OH-DPAT elicits an additive effect that results in full protection of retinal morphology.

10 June 2024 in Ophthalmology
Verified
Journal Article
Closed access
ACAaron S. Coyner
Aaron S. Coyner
BYBenjamin K. Young
Benjamin K. Young
SOSusan R. Ostmo
Susan R. Ostmo
FGFlorin Grigorian
Florin Grigorian
AEAnna Ells
Anna Ells
JCJ. Peter Campbell
J. Peter Campbell

6 April 2023 in Ophthalmology
Verified
Journal Article
Closed access
MDMallory A. Decampos-Stairiker
Mallory A. Decampos-Stairiker
ACAaron S. Coyner
Aaron S. Coyner
AGAditi Gupta
Aditi Gupta
MOMinn Oh
Minn Oh
PSParag K. Shah
Parag K. Shah
JCJ. Peter Campbell
J. Peter Campbell